Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2014

01.06.2014 | Endocrine Tumors

Risk Factors for Recurrence After Therapeutic Lateral Neck Dissection for Primary Papillary Thyroid Cancer

verfasst von: Su-jin Kim, MD, Seog Yun Park, MD, PhD, You Jin Lee, MD, PhD, Eun Kyung Lee, MD, PhD, Seok-ki Kim, MD, PhD, Tae Hyun Kim, MD, PhD, Yu-Seog Jung, MD, PhD, Junsun Ryu, MD, PhD, Jun Pyo Myong, MD, Ki-Wook Chung, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Lateral lymph node metastasis is an important prognostic factor and is predictive of tumor recurrence and cause-specific survival in patients with papillary thyroid cancer (PTC). However, the factors predicting recurrence and clinical outcomes after therapeutic lateral neck dissection are not well established. The aims of this study were to evaluate the incidence, pattern, and factors predictive of PTC recurrence after therapeutic lateral neck dissection.

Materials and Methods

The records of 126 consecutive patients who underwent total thyroidectomy with therapeutic lateral neck dissection for primary PTC at the National Cancer Center were retrospectively reviewed. The factors predictive of recurrence were determined using both univariate and multivariate analyses considering several clinicopathologic variables.

Results

The median follow-up period was 61.2 months, during which 22 patients (17.5 %) experienced recurrence with 1 death (0.8 %) due to disease. Locoregional recurrence and distant metastasis were found in 20 cases (15.9 %) and 2 cases (1.6 %), respectively. Male gender, aggressive histology, number of lymph node metastases, initial level of T4-off Tg per ng/mL, and ATA risk categories (high risk) were independent risk factors for recurrence. Of note, initial T4-off Tg levels greater than 4.2 ng/mL showed highest sensitivity and specificity in predicting recurrence.

Conclusions

These results provide useful information regarding the clinical outcomes after therapeutic lateral neck dissection for primary PTC and can be used to identify at-risk patients who need aggressive treatment and intensive surveillance for postoperative recurrence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996;18:127–32.PubMedCrossRef Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996;18:127–32.PubMedCrossRef
2.
Zurück zum Zitat Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–8.PubMedCrossRef Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–8.PubMedCrossRef
3.
Zurück zum Zitat Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg. 1986;10:612–22.PubMedCrossRef Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg. 1986;10:612–22.PubMedCrossRef
4.
Zurück zum Zitat Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–28.PubMedCrossRef Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–28.PubMedCrossRef
5.
Zurück zum Zitat GH Sakorafas, D Sampanis, M Safioleas. Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol. 2010;19;e57–90.PubMedCrossRef GH Sakorafas, D Sampanis, M Safioleas. Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol. 2010;19;e57–90.PubMedCrossRef
6.
Zurück zum Zitat Lee YS, Kim SW, Kim SW, Kim SK, Kang HS, Lee ES, et al. Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg. 2007;31:1954–9.PubMedCrossRef Lee YS, Kim SW, Kim SW, Kim SK, Kang HS, Lee ES, et al. Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg. 2007;31:1954–9.PubMedCrossRef
7.
Zurück zum Zitat Stack BC, Ferris R, Goldenberg D, Haymart M, Shaha A, Sheth S, Sosa JA, Tufano RP. American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012;22:1–8.CrossRef Stack BC, Ferris R, Goldenberg D, Haymart M, Shaha A, Sheth S, Sosa JA, Tufano RP. American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012;22:1–8.CrossRef
8.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010. Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
9.
Zurück zum Zitat Ito Y, Miyauchi A. Prognostic factors and therapeutic strategies for differentiated carcinoma of the thyroid. Endocr J. 2009;56:177–92.PubMedCrossRef Ito Y, Miyauchi A. Prognostic factors and therapeutic strategies for differentiated carcinoma of the thyroid. Endocr J. 2009;56:177–92.PubMedCrossRef
10.
Zurück zum Zitat Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; validity of UICC/AJCC TNM classification and stage grouping. World J Surg. 2007; 31:838–48.PubMedCrossRef Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; validity of UICC/AJCC TNM classification and stage grouping. World J Surg. 2007; 31:838–48.PubMedCrossRef
11.
Zurück zum Zitat Leboulleux S, Rubino C, Baudin, Caillou B, Hartl DM, Bidart JM, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723–9.PubMedCrossRef Leboulleux S, Rubino C, Baudin, Caillou B, Hartl DM, Bidart JM, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723–9.PubMedCrossRef
12.
Zurück zum Zitat Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71:731–4.PubMed Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71:731–4.PubMed
13.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.PubMedCrossRef Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.PubMedCrossRef
14.
Zurück zum Zitat Lim I, Kim SK, Hwang SS, Kim SW, Chung KW, Kang HS, et al. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer. Ann Nucl Med. 2012;26:777–86.PubMedCrossRef Lim I, Kim SK, Hwang SS, Kim SW, Chung KW, Kang HS, et al. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer. Ann Nucl Med. 2012;26:777–86.PubMedCrossRef
15.
Zurück zum Zitat Foreset VI, Clark JR, Ebrahimi A, Cho EA, Sneddon L, Gao K, et al. Central compartment dissection in thyroid papillary carcinoma. Ann Surg. 2011;253:123–30.CrossRef Foreset VI, Clark JR, Ebrahimi A, Cho EA, Sneddon L, Gao K, et al. Central compartment dissection in thyroid papillary carcinoma. Ann Surg. 2011;253:123–30.CrossRef
16.
Zurück zum Zitat Ricarte-Filho J, Ganly I, Rivera M, Katabi N, Fu W, Shaha A, et al. Papillary thyroid carcinoma with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid. 2012;22:575–84.PubMedCrossRef Ricarte-Filho J, Ganly I, Rivera M, Katabi N, Fu W, Shaha A, et al. Papillary thyroid carcinoma with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid. 2012;22:575–84.PubMedCrossRef
17.
Zurück zum Zitat Siegel R, Naishadham D, Jermal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63:11–30.PubMedCrossRef Siegel R, Naishadham D, Jermal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63:11–30.PubMedCrossRef
18.
Zurück zum Zitat Ito Y, Kudo T, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J Surg. 2012;26:593–7.CrossRef Ito Y, Kudo T, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J Surg. 2012;26:593–7.CrossRef
19.
Zurück zum Zitat Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL. Regional recurrence after lymphadenectomy for clinically evident lymph node metastases form papillary thyroid cancer: a cohort study. Ann Surg Oncol. 2012;19:1453–9.PubMedCrossRef Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL. Regional recurrence after lymphadenectomy for clinically evident lymph node metastases form papillary thyroid cancer: a cohort study. Ann Surg Oncol. 2012;19:1453–9.PubMedCrossRef
20.
Zurück zum Zitat Albuja-Cruz MB, Thorson CM, Allan BJ, Lew JI, Rodgers SE. Number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer does not influence lateral neck recurrence. Surgery. 2012;152:1177–83.PubMedCrossRef Albuja-Cruz MB, Thorson CM, Allan BJ, Lew JI, Rodgers SE. Number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer does not influence lateral neck recurrence. Surgery. 2012;152:1177–83.PubMedCrossRef
21.
Zurück zum Zitat Caron NR, Tan TT, Ogilvie JB, Reiff ES, Kebebew E, Duh QY, et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II, and V dissection always necessary? World J Surg. 2006;30:833–40.PubMedCrossRef Caron NR, Tan TT, Ogilvie JB, Reiff ES, Kebebew E, Duh QY, et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II, and V dissection always necessary? World J Surg. 2006;30:833–40.PubMedCrossRef
22.
Zurück zum Zitat Mazzaferi EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–63.CrossRef Mazzaferi EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–63.CrossRef
23.
Zurück zum Zitat Lin JD, Hsueh C, Chao TC. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome. Thyroid. 2009; 19:1053–1059.PubMedCrossRef Lin JD, Hsueh C, Chao TC. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome. Thyroid. 2009; 19:1053–1059.PubMedCrossRef
24.
Zurück zum Zitat Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005;90:6373–9.PubMedCrossRef Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005;90:6373–9.PubMedCrossRef
25.
Metadaten
Titel
Risk Factors for Recurrence After Therapeutic Lateral Neck Dissection for Primary Papillary Thyroid Cancer
verfasst von
Su-jin Kim, MD
Seog Yun Park, MD, PhD
You Jin Lee, MD, PhD
Eun Kyung Lee, MD, PhD
Seok-ki Kim, MD, PhD
Tae Hyun Kim, MD, PhD
Yu-Seog Jung, MD, PhD
Junsun Ryu, MD, PhD
Jun Pyo Myong, MD
Ki-Wook Chung, MD, PhD
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3507-y

Weitere Artikel der Ausgabe 6/2014

Annals of Surgical Oncology 6/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.